Eisai (Singapore) Pte Ltd
Eisai (Singapore) Pte. Ltd. is a pharmaceutical subsidiary of Eisai Co., Ltd., based in Tokyo, Japan.
Listing updated
About Eisai (Singapore) Pte Ltd
Eisai (Singapore) Pte. Ltd. is a pharmaceutical subsidiary of Eisai Co., Ltd., based in Tokyo, Japan. The company positions neurology and oncology as its therapeutic areas of focus and develops and markets prescription medicines in these areas. Its corporate mission is human health care (hhc), contributing to patients and meeting diversified healthcare needs worldwide.
Eisai (Singapore) promotes medicines as Product Registrant holder in Singapore, including LEQEMBI® (lecanemab), approved by the Health Sciences Authority of Singapore for slowing the progression of early Alzheimer's disease. Eisai Co., Ltd. was founded in Japan in 1941 and has more than 10,000 employees worldwide.
- Category
- Pharmaceutical company
- Location
- Singapore
- Website
- eisai.com.sg
Summary written with AI from public business data. Disclaimer
Products & services
- Prescription medicines in neurology
- Prescription medicines in oncology
- LEQEMBI® (lecanemab) for early Alzheimer's disease
- Aricept (donepezil hydrochloride) for Alzheimer's disease
- Fycompa (perampanel) for epilepsy
- Lenvima (lenvatinib) for oncology indications
- Halaven (eribulin mesylate) for breast cancer / liposarcoma
- Tysabri (natalizumab) for multiple sclerosis
Tap a product to find other suppliers of it.
Location
Quick facts
- Business name
- Eisai (Singapore) Pte Ltd
- What it supplies
- Eisai (Singapore) Pte Ltd is listed under Pharmaceutical company.
- Category
- Pharmaceutical company
- Location
- Singapore
- Listed products and services
- Prescription medicines in neurology, Prescription medicines in oncology, LEQEMBI® (lecanemab) for early Alzheimer's disease, Aricept (donepezil hydrochloride) for Alzheimer's disease, Fycompa (perampanel) for epilepsy, Lenvima (lenvatinib) for oncology indications, Halaven (eribulin mesylate) for breast cancer / liposarcoma, Tysabri (natalizumab) for multiple sclerosis. (Summarised with AI from public business data.)
- How to contact
- Phone, website and an enquiry form on this page.
- Listing last updated